Basic Information
Basic information for NR2F1-AS1-219-16aa-2
Peptide Name NR2F1-AS1-219-16aa-2
Genome Position chr5:93411125-93411172[-]
Species Human
Peptide Sequence MIPFNLISKKILFAPQ
Peptide Length 16
Unique No (NR2F1-AS1-204-16aa-2,NR2F1-AS1-213-16aa-2,NR2F1-AS1-216-16aa-2,NR2F1-AS1-220-16aa-2,NR2F1-AS1-224-16aa-2,NR2F1-AS1-225-16aa-2,NR2F1-AS1-226-16aa-2,NR2F1-AS1-230-16aa-2,NR2F1-AS1-231-16aa-2,NR2F1-AS1-232-16aa-2,NR2F1-AS1-234-16aa-2,NR2F1-AS1-236-16aa-2,NR2F1-AS1-238-16aa-2,NR2F1-AS1-239-16aa-2,NR2F1-AS1-240-16aa-2,NR2F1-AS1-245-16aa-2,NR2F1-AS1-247-16aa-2,NR2F1-AS1-248-16aa-2,NR2F1-AS1-251-16aa-2,NR2F1-AS1-252-16aa-2,NR2F1-AS1-259-16aa-2,NR2F1-AS1-260-16aa-2,NR2F1-AS1-261-16aa-3,NR2F1-AS1-264-16aa-2,NR2F1-AS1-267-16aa-2,NR2F1-AS1-273-16aa-2,NR2F1-AS1-274-16aa-2,NR2F1-AS1-275-16aa-2)
Grand Average of Hydropathicity 0.725
Relative Molecular Mass 2130.53
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000237187;NR2F1-AS1
Transcript ID/Name ENST00000653325;NR2F1-AS1-219
Transcript Length 3370
Coding Ability 0.3662
DNA Sequence Corresponding to Peptide ATGATCCCTTTTAACTTAATTTCTAAAAAAATATTATTTGCTCCTCAG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :